CP-809101 is primarily researched for its potential therapeutic applications in the field of neuroscience. It acts as a selective antagonist for the 5-HT2C receptor, which plays a significant role in regulating mood, appetite, and anxiety. This compound has been studied for its potential to treat conditions such as depression, obesity, and anxiety disorders by modulating serotonin signaling pathways. Additionally, its ability to influence appetite regulation makes it a candidate for addressing metabolic disorders. Research is ongoing to explore its efficacy and safety in clinical settings.